Our three founders have over 60 years of combined experience in the medical device and pharmaceutical industries, including 25 years in start-ups, and 35 years in manufacturing and operations. Our leadership has a proven track record of innovation, launching ground-breaking products that have transformed markets and driven significant exits, with prior ventures reaching valuations between $450M and $1.9B.
With deep expertise in advanced biotechnology, product development, and business strategy, the Re-GeneRox team is well equipped to drive innovation and respond to evolving market demands in the skincare and biotech space.
